Development of Enzyme-Linked Immunosorbent Assay for Determination of Boldenone in Dietary Supplements
- 195 Downloads
There is an increasing interest in the investigation and implementation of methods for the analysis of anabolic steroids in dietary supplements. In this study, a competitive indirect enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of boldenone. For this purpose, an antiserum against boldenone was raised in a rabbit using boldenone-17-hemisuccinate-bovine serum albumin as an immunization conjugate. Based on the ELISA standard curve, the detection limit was as low as 0.014 ± 0.007 ng mL−1 with the IC50 value of 0.293 ± 0.084 ng mL−1 and linear working range of 0.065–1.529 ng mL−1. The intra- and inter-assay variations were found to be satisfactory. Relative standard deviations were calculated in the range of 3.8–10.5 and 7.3–12.9 %. The developed ELISA was applied in the analysis of extracts obtained from spiked samples of dietary supplements. Ethanol extracts were applied into the immunoassay without a cleanup procedure (only diluted) to minimize the effect of the matrix. Recoveries from spiked samples were from 86.0 to 115.7 %. An excellent correlation between ELISA and UHPLC-MS/MS was obtained with the linear equation of y = 1.0256 x − 0.7772 (R 2 = 0.9999). This ELISA as proposed here could be successfully applied for the simple monitoring of boldenone in dietary supplements.
KeywordsELISA Boldenone Anabolic steroid Dietary supplement
This work was supported by the Grant of the Ministry of the Interior of the Czech Republic (VG20112015045).
Compliance with Ethical Standards
This study was funded by Ministry of the Interior of the Czech Republic (grant number VG20112015045).
Conflict of Interest
Lucie Fojtíková has no conflict of interest. Ladislav Fukal has no conflict of interest. Martina Blažková has no conflict of interest. Sandra Sýkorová has no conflict of interest. Martin Kuchař has no conflict of interest. Petra Mikšátková has no conflict of interest. Oldřich Lapčík has no conflict of interest. Barbora Holubová has no conflict of interest.
All applicable international, national, and/or institutional guidelines for the care and use of laboratory animals were followed.
Informed consent was obtained from all the individual participants involved in the study.
- Destrez B et al (2009) Criteria to distinguish between natural situations and illegal use of boldenone, boldenone esters and boldione in cattle 2. Direct measurement of 17beta-boldenone sulpho-conjugate in calf urine by liquid chromatography-high resolution and tandem mass spectrometry. Steroids 74:803–808CrossRefGoogle Scholar
- Draisci R, Palleschi L, Ferretti E, Lucentini L, delli Quadri F (2003) Confirmatory analysis of 17beta-boldenone, 17alpha-boldenone and androsta-1,4-diene-3,17-dione in bovine urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 789:219–226CrossRefGoogle Scholar
- Odoardi S, Castrignano E, Martello S, Chiarotti M, Strano-Rossi S (2015) Determination of anabolic agents in dietary supplements by liquid chromatography-high-resolution mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 32:635–647Google Scholar
- Stepan R, Cuhra P, Barsova S (2008) Comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometric detection for the determination of anabolic steroids and related compounds in nutritional supplements. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:557–565CrossRefGoogle Scholar